The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for B Premsai Reddy & PACs
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Promoter B Premsai Reddy and his PACs (which include Prajitha Bandaram, Satyavathi Bandaram, Deepak Reddy B, Lalanthika, M. Seetharama Reddy and M. Sukumari) have acquired 22,54,484 equity shares, representing 12.54% of the post-allotment capital of Bandaram Pharma Packtech Ltd. The acquisition happened on 06 November 2025 through a preferential allotment, which increased the company's total equity from 1,20,00,000 shares to 1,79,71,920 shares. The promoter group's combined holding went from 75.00% (90,00,000 shares) to 62.62% (1,12,54,484 shares) of the expanded capital, reflecting partial dilution even as the promoters subscribed to fresh shares. No shares were sold, encumbered or invoked in this transaction.
This is a sign of promoter confidence as they are putting in fresh capital via preferential allotment, though their percentage stake has diluted from 75% to about 62.6% due to the capital expansion. For retail shareholders, the issue of new shares to promoters signals continued promoter commitment, but existing shareholders face dilution and should look out for the preferential issue price and terms.